Abstract
The transforming-growth-factor-β-activated kinase TAK1 is a member of the mitogen-activated protein kinase kinase kinase family, which couples extracellular stimuli to gene transcription. The in vivo function of TAK1 is not understood. Here, we investigated the potential involvement of TAK1 in cardiac hypertrophy. In adult mouse myocardium, TAK1 kinase activity was upregulated 7 days after aortic banding, a mechanical load that induces hypertrophy and expression of transforming growth factor β. An activating mutation of TAK1 expressed in myocardium of transgenic mice was sufficient to produce p38 mitogen-activated protein kinase phosphorylation in vivo , cardiac hypertrophy, interstitial fibrosis, severe myocardial dysfunction, ‘fetal’ gene induction, apoptosis and early lethality. Thus, TAK1 activity is induced as a delayed response to mechanical stress, and can suffice to elicit myocardial hypertrophy and fulminant heart failure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
MacLellan, W.R. & Schneider, M.D. in Cardiac Development (eds. Harvey, R. & Rosenthal, N.) 405– 427 (Academic Press, San Diego, 1998).
Sadoshima, J. & Izumo, S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59, 551–571 (1997).
MacLellan, W.R. & Schneider, M.D. Death by design - Programmed cell death in cardiovascular biology and disease. Circ. Res. 81, 137–144 ( 1997).
Adams, J.W. et al. Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl. Acad. Sci. USA 95, 10140–10145 ( 1998).
Hirota, H. et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97, 189–198 ( 1999).
Wang, Y.B. et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273, 2161–2168 (1998).
Nemoto, S., Sheng, Z.L. & Lin, A.N. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol. Cell. Biol. 18, 3518–3526 ( 1998).
Yamaguchi, K. et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008–2011 (1995).
Moriguchi, T. et al. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 271, 13675–13679 (1996).
Ninomiya-Tsuji, J. et al. The kinase TAK1 can activate the NIK-I kappa B as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252–256 (1999).
Villarreal, F.J. & Dillmann, W.H. Cardiac hypertrophy-induced changes in mRNA levels for TGF-β 1, fibronectin, and collagen. Am. J. Physiol. 262, H1861–1866 (1992).
Parker, T.G., Packer, S.E. & Schneider, M.D. Peptide growth factors can provoke “fetal” contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85, 507–514 (1990).
Shirakabe, K. et al. TAK1 mediates the ceramide signaling to stress-activated protein kinase c-Jun N-terminal kinase. J. Biol. Chem. 272, 8141–8144 (1997).
Sano, Y. et al. ATF-2 Is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J. Biol. Chem. 274, 8949–8957 (1999).
Kretzschmar, M. & Massague, J. SMADs: mediators and regulators of TGF-β signaling. Curr. Opin. Genet. Dev. 8, 103–111 ( 1998).
MacLellan, W.R., Lee, T.C., Schwartz, R.J. & Schneider, M.D. Transforming growth factor-beta response elements of the skeletal alpha-actin gene: Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. J. Biol. Chem. 269, 16754 –16760 (1994).
Paradis, P., Maclellan, W.R., Belaguli, N.S., Schwartz, R.J. & Schneider, M.D. Serum response factor mediates AP-1-dependent induction of the skeletal α-actin promoter in ventricular myocytes. J. Biol. Chem. 271, 10827– 10833 (1996).
Thuerauf, D.J. et al. p38 mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element. A potential role for the transcription factor ATF6. J. Biol. Chem. 273, 20636–20643 ( 1998).
Croissant, J.D. et al. Avian serum response factor expression restricted primarily to muscle cell lineages is required for α-actin gene transcription. Dev Biol 177, 250–264 ( 1996).
Chen, C.Y. & Schwartz, R.J. Recruitment of the tinman homolog nkx-2.5 by serum response factor activates cardiac α-actin gene transcription . Mol. Cell. Biol. 16, 6372– 6384 (1996).
Zhu, C., Johansen, F.E. & Prywes, R. Interaction of ATF6 and serum response factor. Mol. Cell. Biol. 17, 4957–4966 (1997).
Raingeaud, J., Whitmarsh, A.J., Barrett, T., Derijard, B. & Davis, R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16, 1247– 1255 (1996).
Boluyt, M.O. et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 75, 23–32 (1994).
Molkentin, J.D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215– 228 (1998).
Georgakopoulos, D. et al. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation. Nature Med. 5, 327– 330 (1999).
Taffet, G.E. et al. Noninvasive indexes of cardiac systolic and diastolic function in hyperthyroid and senescent mouse. Am. J. Physiol. 270, H2204–2209 (1996).
Hartley, C.J., Michael, L.H. & Entman, M.L. Noninvasive measurement of ascending aortic blood velocity in mice. Am. J. Physiol. 268, H499 –505 (1995).
Brown, T.L., Patil, S., Cianci, C.D., Morrow, J.S. & Howe, P.H. Transforming growth factor β induces caspase 3-independent cleavage of αII-spectrin (α-fodrin) coincident with apoptosis. J. Biol. Chem. 274, 23256– 23262 (1999).
Yamazaki, T. et al. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J. Clin. Invest. 96, 438–446 (1995).
Charng, M.J. et al. A constitutive mutation of ALK5 disrupts cardiac looping and morphogenesis in mice. Dev. Biol. 199, 72 –79 (1998).
Kapadia, S.R. et al. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ. Res. 81, 187–195 (1997).
Shioi, T. et al. Increased expression of interleukin-1β and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ. Res. 81, 664–671 (1997).
Monzen, K. et al. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4. Mol. Cell. Biol. 19, 7096–7105 ( 1999).
Agah, R. et al. Gene recombination in postmitotic cells: Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. 100, 169–179 (1997).
Abdellatif, M., MacLellan, W.R. & Schneider, M.D. p21 Ras as a governor of global gene expression. J. Biol. Chem. 269, 15423–15426 (1994).
Wrana, J.L. et al. TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71, 1003– 1014 (1992).
Ornitz, D.M., Moreadith, R.W. & Leder, P. Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements . Proc. Natl. Acad. Sci. USA 88, 698– 702 (1991).
Johansen, F.E. & Prywes, R. Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs. Mol. Cell. Biol. 13, 4640–4647 (1993).
Sadowski, I. & Ptashne, M. A vector for expressing GAL4(1–147) fusions in mammalian cells. Nucleic Acids Res. 17, 7539 (1989).
Jiang, W. & Hunter, T. Identification and characterization of a human protein kinase related to budding yeast Cdc7p. Proc. Natl. Acad. Sci. USA 94, 14320–14325 (1997).
Kirshenbaum, L.A., Abdellatif, M., Chakraborty, S. & Schneider, M.D. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev. Biol. 179 , 402–411 (1996).
Subramaniam, A. et al. Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266 , 24613–24620 (1991).
Depre, C. et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nature Med. 4, 1269 –1275 (1998).
Ritter, S.J. & Davies, P.J.A. Identification of a transforming growth factor-β 1/bone morphogenetic protein 4 (TGF-β1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 273, 12798–12806 (1998).
Rindt, H., Gulick, J., Knotts, S., Neumann, J. & Robbins, J. In vivo analysis of the murine β-myosin heavy chain gene promoter. J. Biol. Chem. 268, 5332–5338 (1993).
Acknowledgements
We thank B. Boerwinkle, T. Pham and F. Ervin for technical assistance; P. Davies and G. Shipley for access to instrumentation for real-time RT–PCR, M. Abdellatif and R. MacLellan for comments, and R. Roberts for encouragement and support. A.Z. was a PhD candidate in the DeBakey Heart Center Graduate Program in Cardiovascular Sciences. This work was supported in part by grants from the National Institutes of Health, the National Aeronautics and Space Administration, and the Dunn Foundation to M.D.S.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, D., Gaussin, V., Taffet, G. et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 6, 556–563 (2000). https://doi.org/10.1038/75037
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/75037
This article is cited by
-
The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications
Journal of Biomedical Science (2022)
-
Transforming growth factor-β in myocardial disease
Nature Reviews Cardiology (2022)
-
AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis
Scientific Reports (2021)
-
6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway
Acta Pharmacologica Sinica (2021)
-
TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
Bone Research (2021)